On Tuesday, JFrog got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 86.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners tend to have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
JFrog has risen more than 5% past a 35.35 entry in a first-stage flat base, meaning it's now out of a proper buy zone. Look for the stock to create a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company reported 0% earnings growth last quarter. Revenue increased 19%.
JFrog holds the No. 42 rank among its peers in the Computer Software-Enterprise industry group. Enfusion, Samsara and Klaviyo are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
